Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis.
作者信息
Garcia-Tsao Guadalupe, Friedman Scott, Iredale John, Pinzani Massimo
机构信息
Section of Digestive Diseases, Yale University School of Medicine, VA Connecticut Healthcare System, New Haven, CT, USA.
出版信息
Hepatology. 2010 Apr;51(4):1445-9. doi: 10.1002/hep.23478.
Abstract
摘要
相似文献
1
Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis.现在存在许多（阶段），而以前只有一个：寻找肝硬化的病理生理分类。
Hepatology. 2010 Apr;51(4):1445-9. doi: 10.1002/hep.23478.
2
[Physiopathology of liver cirrhosis in relation to the liver lesion].
Nihon Naika Gakkai Zasshi. 1991 Oct 10;80(10):1568-71.
3
Cirrhosis: what else?
Gastroenterol Clin Biol. 2010 Apr-May;34(4-5):252-4. doi: 10.1016/j.gcb.2010.03.007. Epub 2010 May 27.
4
Evaluation of rectal mucosal hemodynamics in patients with liver cirrhosis using reflectance spectrophotometry.使用反射分光光度法评估肝硬化患者的直肠黏膜血流动力学。
Am J Gastroenterol. 1997 Jun;92(6):1022-5.
5
[Liver cirrhosis, its definition and classification--from a morbid anatomical point of view].
Nihon Rinsho. 1994 Jan;52(1):5-10.
6
Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis.心肺血液动力学和 C 反应蛋白作为代偿性和失代偿性肝硬化的预后指标。
J Hepatol. 2018 May;68(5):949-958. doi: 10.1016/j.jhep.2017.12.027. Epub 2018 Jan 10.
7
[Child-Pugh classification in liver cirrhosis].
Ryoikibetsu Shokogun Shirizu. 1995(7):151-4.
8
Cirrhosis of the liver: principles of classification, histogenesis, and pathogenesis.肝硬化：分类、组织发生及发病机制原理
Pathol Annu. 1972;7:107-44.
9
Clinical vs hemodynamic classification of cirrhosis.
Surg Forum. 1975;26:417-9.
10
Classification of cirrhosis.
Am J Gastroenterol. 1975 Dec;64(6):437-51.
引用本文的文献
1
S index: a predictor comparable to ultrasound shear wave elastography in assessing liver fibrosis in patients with chronic hepatitis B.S指数：一种在评估慢性乙型肝炎患者肝纤维化方面可与超声剪切波弹性成像相媲美的预测指标。
BMC Med Imaging. 2025 Jul 28;25(1):296. doi: 10.1186/s12880-025-01846-3.
2
The Treatment of Primary Biliary Cholangitis: Time for Personalized Medicine.原发性胆汁性胆管炎的治疗：个性化医疗时代已来。
Clin Rev Allergy Immunol. 2025 Jul 12;68(1):63. doi: 10.1007/s12016-025-09074-x.
3
Precise cell therapy for liver fibrosis: Endothelial cell and macrophage therapy.肝纤维化的精准细胞治疗：内皮细胞和巨噬细胞治疗
ILIVER. 2022 Nov 19;1(4):265-274. doi: 10.1016/j.iliver.2022.11.002. eCollection 2022 Dec.
4
Digital Pathology Quantification of the Continuum of Cirrhosis Severity in Human Liver Biopsies.人类肝脏活检中肝硬化严重程度连续体的数字病理学量化
Liver Int. 2025 Jul;45(7):e70166. doi: 10.1111/liv.70166.
5
AI-Cirrhosis-ECG (ACE) score for predicting decompensation and liver outcomes.用于预测失代偿和肝脏预后的人工智能-肝硬化-心电图（ACE）评分
JHEP Rep. 2025 Feb 19;7(5):101356. doi: 10.1016/j.jhepr.2025.101356. eCollection 2025 May.
6
Disease trajectory and competing risks of patients with cirrhosis in the US.美国肝硬化患者的疾病轨迹和竞争风险。
PLoS One. 2025 Feb 14;20(2):e0313152. doi: 10.1371/journal.pone.0313152. eCollection 2025.
7
Immunosuppressive treatment in autoimmune decompensated cirrhosis, when to say enough: A retrospective analysis.自身免疫性失代偿期肝硬化的免疫抑制治疗，何时应适可而止：一项回顾性分析。
Medicine (Baltimore). 2025 Feb 7;104(6):e41378. doi: 10.1097/MD.0000000000041378.
8
Advanced glycation end products and risk of mortality in patients with cirrhosis: a prospective cohort study.晚期糖基化终末产物与肝硬化患者的死亡风险：一项前瞻性队列研究。
Sci Rep. 2025 Feb 8;15(1):4798. doi: 10.1038/s41598-025-89433-y.
9
Protective effect of long-chain polyunsaturated fatty acids on hepatorenal syndrome in rats.长链多不饱和脂肪酸对大鼠肝肾综合征的保护作用。
World J Nephrol. 2024 Sep 25;13(3):95627. doi: 10.5527/wjn.v13.i3.95627.
10
Liver fibrosis: Our evolving understanding.肝纤维化：我们不断发展的认识。
Clin Liver Dis (Hoboken). 2024 Jul 3;23(1):e0243. doi: 10.1097/CLD.0000000000000243. eCollection 2024 Jan-Jun.
本文引用的文献
1
Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.肝静脉压力梯度可独立于肝硬化严重程度预测肝细胞癌的发生。
J Hepatol. 2009 May;50(5):923-8. doi: 10.1016/j.jhep.2009.01.014. Epub 2009 Mar 5.
2
Angiogenesis in liver disease.肝脏疾病中的血管生成
J Hepatol. 2009 Mar;50(3):604-20. doi: 10.1016/j.jhep.2008.12.011. Epub 2008 Dec 31.
3
Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats.索拉非尼对门静脉高压和肝硬化大鼠内脏、肝内及门体侧支循环的有益作用。
Hepatology. 2009 Apr;49(4):1245-56. doi: 10.1002/hep.22758.
4
Elastography for the non-invasive assessment of liver disease: limitations and future developments.用于肝脏疾病无创评估的弹性成像：局限性与未来发展
Gut. 2009 Feb;58(2):157-60. doi: 10.1136/gut.2008.156489.
5
Mechanisms of hepatic fibrogenesis.肝纤维化形成机制。
Gastroenterology. 2008 May;134(6):1655-69. doi: 10.1053/j.gastro.2008.03.003.
6
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.肝静脉压力梯度可预测代偿期肝硬化患者的临床失代偿情况。
Gastroenterology. 2007 Aug;133(2):481-8. doi: 10.1053/j.gastro.2007.05.024. Epub 2007 May 21.
7
Transient elastography for diagnosis of portal hypertension in liver cirrhosis: is there still a role for hepatic venous pressure gradient measurement?瞬时弹性成像在肝硬化门静脉高压诊断中的应用：肝静脉压力梯度测量是否仍有作用？
Hepatology. 2007 May;45(5):1087-90. doi: 10.1002/hep.21731.
8
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis.肝脏硬度测量可预测丙型肝炎病毒相关性肝硬化患者的严重门静脉高压。
Hepatology. 2007 May;45(5):1290-7. doi: 10.1002/hep.21665.
9
Vascular endothelial dysfunction in cirrhosis.肝硬化中的血管内皮功能障碍
J Hepatol. 2007 May;46(5):927-34. doi: 10.1016/j.jhep.2007.02.006. Epub 2007 Mar 5.
10
Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation.瞬时弹性成像在肝移植后丙型肝炎复发患者中诊断重度肝纤维化和门静脉高压的应用
Liver Transpl. 2006 Dec;12(12):1791-8. doi: 10.1002/lt.20857.
Zotero 插件